Bird Flu
Biota Says New Evidence Details GSK's Comprehensive Failures to Support Anti-Influenza Drug Relenza, Compromising Global Preparedness for Avian Flu
Published in Medical Verdicts and Law Weekly, April 12th, 2007
After a two year review of more than 200,000 GlaxoSmithKline (GSK) documents, Biota Holdings Limited today filed an Amended Statement of Claim with the Victorian Supreme Court that Biota says provides great detail of its allegation that GSK consistently mismanaged its legal obligation to develop and market the anti-viral drug Relenza(R) (zanamivir)(1). Relenza is one of only two specific anti-influenza drugs recommended by the World Health Organization for global stockpiling to protect against pandemic influenza, including Avian flu.
Today's amended Statement of Claim updates a writ Biota filed with the Victorian Supreme Court in May 2004, which sought unspecified...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Verdicts and Law Weekly
More Articles from Medical Verdicts and Law Weekly
- AARP
AARP Teams With Iowa Business, Industry, Education and Labor to Spur Action on Health Care, Long-Term Financial Security - American Nurses Association
ANA Statement on H.R. 1644/S. 969: The Re-Empowerment of Skilled and Professional Employees and Construction Tradeworkers (Respect) Act - AMERIGROUP Corporation
AMERIGROUP Prices $240 Million in Convertible Senior Notes - Biomedical Engineering
China Medical Technologies and the Biomed-X Center of Peking University Establish New Research Laboratory to Develop Medical Devices - California United Homecare Workers
Healthcare Community Denounces Anti-Care Proposal - CanAmerica Global
Former Springfield, Massachusetts Mayor Michael Albano Announces Affiliation with Global Provider of Prescription Medications - More from this issue of Medical Verdicts and Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
